Dysregulation of glucocorticoid metabolism in murine obesity: Comparable effects of leptin resistance and deficiency

Journal of Endocrinology

Volumn 201, Issue 2, 2009, Pages 211-218

  Livingstone, Dawn E W ^a   Grassick, Sarah I ^a   Currie, Gillian L ^a   Walker, Brian R ^a   Andrew, Ruth ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GLUCOCORTICOID; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; STEROID 5BETA REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; ENZYME ACTIVITY; GENE EXPRESSION; HORMONE DEFICIENCY; HORMONE RESISTANCE; LEPTIN DEFICIENCY; LEPTIN RESISTANCE; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; ADIPOSE TISSUE; ANIMAL; BIOLOGICAL MODEL; DRUG RESISTANCE; EXPERIMENTAL DIABETES MELLITUS; GENETICS; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DRUG RESISTANCE; GLUCOCORTICOIDS; LEPTIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MODELS, BIOLOGICAL; OBESITY; RECEPTORS, LEPTIN;

EID: 67650711628     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0003     Document Type: Article

References (55)

1. Alberts P, Engblom L, Edling N, Forsgren M, Klingstrom G, Larsson C, Rönquist-Nii Y, Öhman B & Abrahmsén L 2002 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45 1528-1532.
2. Andrew R & Walker BR 2002 Glucocorticoid metabolism in health and disease. Recent Research Developments in Endocrinology 3 425-449.
3. Andrew R, Phillips DIW & Walker BR 1998 Obesity and gender influence cortisol secretion and metabolism in man. Journal of Clinical Endocrinology and Metabolism 83 1806-1809.
4. Barat P, Livingstone DEW, Elferink C, MacDonnell R, Walker BR & Andrew R 2007 Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats. Endocrinology 148 4836-4843.
5. Bujalska IJ, Kumar S & Stewart PM 1997 Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 349 1210-1213.
6. Bujalska IJ, Draper N, Michailidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA & Stewart PM 2005 Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. Journal of Molecular Endocrinology 34 675-684.
7. Chua SC, Chung WK, Wu-Peng XS, Zhang Y, Liu S-M, Tartaglia L & Leibel RL 1996 Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271 994-996.
8. Cohen B, Novick D & Rubinstein M 1996 Modulation of insulin activities by leptin. Science 274 1185-1188.
9. Drake AJ, Livingstone DEW, Morton NM, Andrew R, Seckl JR & Walker BR 2005 Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high fat feeding in rats. Endocrinology 146 913-919.
10. Eicheler W, Seitz J, Steinhoff M, Forssmann WG, Adermann K & Aumuller G 1995 Distribution of rat hepatic steroid 5alpha-reductase 1 as shown by immunohistochemistry. Experimental and Clinical Endocrinology and Diabetes 103 105-112.
11. Einarsson K & Gustafsson J-A 1973 Neonatal imprinting of liver microsomal hydroxylation and reduction of steroids. Journal of Biological Chemistry 248 4987-4997.
12. Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E & Connell JMC 1999 Cortisol effects on body mass, blood pressure, and cholesterol in the general population. American Journal of Physiology. Endocrinology and Metabolism 33 1364-1368.
13. Gilmour JS, Coutinho AE, Cailhier J-F, Man TY, Clay M, Thomas G, Harris HG, Mullins JJ, Seckl JR, Savill JS et al. 2006 Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes. Journal of Immunology 176 7605-7611.
14. Goedecke JH, Wake DJ, Levitt NS, Lambert EV, Collins MR, Morton NM, Andrew R, Walker BR & Seckl JR 2006 Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome. Clinical Endocrinology 65 81-87.
15. Gustafsson J-A & Stenberg A 1974 Irreversible androgenic programming at birth of microsomal and soluble rat liver steroid metabolism by neonatal testosterone. Journal of Biological Chemistry 249 711-718.
16. Hermanowski-Vosatka A, Gerhold D, Mundt SS, Loving VA, Lu M, Chen Y, Elbrecht A, Wu M, Doebber T, Kelly L et al. 2000 PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver. Biochemical and Biophysical Research Communications 279 330-336.
17. Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS et al. 2005 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. Journal of Experimental Medicine 202 517-527.
18. Hoggard N, Mercer JG, Rayner DV, Moar K, Trayhurn P & Williams LM 1997 Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochemical and Biophysical Research Communications 232 383-387.
19. Holmes MC, French KL & Seckl JR 1995 Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Molecular Brain Research 28 186-192.
20. Horton R, Pasupuletti V & Antonipillai I 1993 Androgen induction of steroid 5α-reductase may be mediated via insulin-like growth factor-1. Endocrinology 133 447-451.
21. Jamieson PM, Chapman KE, Edwards CRW & Seckl JR 1995 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 136 4754-4761.
22. Jang C, Obeyesekere VR, Dilley RJ, Alford FP & Inder WJ 2006 11β-Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle. Clinical Endocrinology 65 800-805.
23. Jansson JO, Ekberg S & Isaksson O 1985 Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone. Endocrinology 117 1881-1889.
24. Lee G-H, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI & Friedman JM 1996 Abnormal splicing of the leptin receptor in diabetic mice. Nature 379 632-635.
25. Lindsay RS, Tataranni A, Permana P, Livingstone DEW, Wake DJ & Walker BR 2003 Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and mRNA levels are associated with adiposity and insulinaemia in Pima Indians and Caucasians. Journal of Clinical Endocrinology and Metabolism 88 2738-2744.
26. Liu Y, Nakagawa Y, Wang Y, Li R, Li X, Ohzeki T & Friedman TC 2003 Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycaemia in leptin deficient ob/ob mice. Diabetes 52 1409-1416.
27. Liu Y, Nakagawa Y, Wang Y, Sakurai R, Tripathi PV, Lutfy K & Friedman TC 2005 Increased glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes 54 32-40.
28. Livingstone DEW, Jones GC, Smith K, Andrew R, Kenyon CJ & Walker BR 2000 Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141 560-563.
29. Livingstone DEW, McInnes KJ, Walker BR & Andrew R 2005 Increased A-ring reduction of glucocorticoids in obese rats: attenuation by insulin sensitisation. Obesity Research 13 1523-1526.
30. Low SC, Moisan M-P, Edwards CRW & Seckl JR 1994 Glucocorticoids and chronic stress up-regulate 11b-hydroxysteroid dehydrogenase activity and gene expression in the hippocampus. Journal of Neuroendocrinology 6 285-290.
31. Mahendroo MS, Cala KM & Russell DW 1996 5α-Reduced androgens play a key role in murine parturition. Molecular Endocrinology 10 380-392.
32. Mahendroo MS, Cala KM, Hess DL & Russell DW 2001 Unexpected virilization in male mice lacking steroid 5α-reductase enzymes. Endocrinology 142 4652-4662.
33. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ & Seckl JR 2004 Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53 931-938.
34. Morton NM, Densmore V, Wamil M, Ramage L, Nichol K, Bunger L, Seckl JR & Kenyon CJ 2005 A polygenic model of the Metabolic Syndrome with reduced circulating and intra-adipose glucocorticoid action. Diabetes 54 3371-3378.
35. Nakano K, Inada Y, Masuzaki H, Tanaka T, Yasue S, Ishii T, Arai N, Ebihara K, Hosada K, Maruyama K et al. 2007 Bezafibrate regulated the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes. American Journal of Physiology. Endocrinology and Metabolism 292 E1213-E1222.
36. Opperman UC, Netter KJ & Maser E 1995 Cloning and primary structure of murine 11β-hydroxysteroid microsomal carbonyl reductase. European Journal of Biochemistry 227 202-208.
37. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC & Grino M 2002 Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridisation study. Journal of Clinical Endocrinology and Metabolism 87 2701-2705.
38. Phillips DIW, Walker BR, Reynolds RM, Flanagan DEH, Wood PJ, Osmond C, Barker DJ & Whorwood CB 2000 Low birthweight predicts elevated plasma cortisol concentrations in adults from three populations. Journal of Internal Medicine 35 1301-1306.
39. Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DEW, Johnson O & Walker BR 2001 Tissue-specific dysregulation of cortisol metabolism in human obesity. Journal of Clinical Endocrinology and Metabolism 86 1418-1421.
40. Rask E, Walker BR, Söderberg S, Livingstone DEW, Eliasson M, Johnson O, Andrew R & Olsson T 2002 Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. Journal of Clinical Endocrinology and Metabolism 87 3330-3336.
41. Raubenheimer PJ, Nyirenda MJ & Walker BR 2006 A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet. Diabetes 55 2015-2020.
42. Sahai M, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM & Whittington PF 2004 Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. American Journal of Physiology. Gastrointestinal and Liver Physiology 287 G1035-G1043.
43. Da Silva BA, Bjorbaek C, Uotani S & Flier JS 1998 Functional properties of leptin receptor isoforms containing the Gln-Pro extracellular domain mutation of the fatty rat. Endocrinology 139 3681-3690.
44. Surmi BK & Hasty AH 2008 Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidology 3 545-556.
45. Tomlinson JW, Finney J, Hughes BA, Hughes S & Stewart PM 2008 Reduced glucocorticoid production rate, decreased 5α-reductase activity and adipose tissue insulin sensitization following weight loss. Diabetes 57 1536-1543.
46. Tsilchorozidou T, Honour JW & Conway GS 2003 Altered cortisol metabolism in Polycystic Ovary Syndrome: insulin enhances 5α-reduction but not the elevated adrenal steroid production rates. Journal of Clinical Endocrinology and Metabolism 88 5907-5913.
47. Voice MW, Seckl JR, Edwards CRW & Chapman KE 1996 11beta-Hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism. Biochemical Journal 317 621-625.
48. Wake DJ, Rask E, Livingstone DEW, Soderberg S, Olsson T & Walker BR 2003 Local and systemic impact of transcriptional upregulation of 11β-hydroxysteroid dehydrogenase type 1 in human adipose tissues in obesity. Journal of Clinical Endocrinology and Metabolism 88 3983-3988.
49. Wake DJ, Stimson RH, Tan GD, Andrew R, Homer NZM, Karpe F & Walker BR 2007α Influence of peroxisome proliferator-activated receptor (PPAR) α and γ agonists on 11β-hydroxysteroid dehydrogenase type 1 in vivo in humans. Journal of Clinical Endocrinology and Metabolism 92 1848-1856.
50. Wake DJ, Strand M, Rask E, Westerbacka J, Livingstone DEW, Soderberg S, Andrew R, Olsson T, Yki-Jarvinen H & Walker BR 2007b The influence of intra-adipose enzymes generating estrogens and androgens on body fat distribution in idiopathic human obesity. Clinical Endocrinology 66 440-446.
51. Walker BR & Andrew R 2006 Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Annals of the New York Academy of Sciences 1083 165-184.
52. Westerbacka J, Yki-Jarvinen H, Vehkavaara S, Häkkinen A-M, Andrew R, Wake DJ, Seckl JR & Walker BR 2003 Body fat distribution and cortisol metabolism in healthy men: enhanced 5β-reductase and lower cortisol/ cortisone metabolite ratios in men with fatty liver. Journal of Clinical Endocrinology and Metabolism 88 4924-4931.
53. Whitaker EM, Shaw MA & Hervey GR 1983 Plasma oestradiol-17beta and testosterone concentrations as possible causes of the infertility of congenitally obese Zucker rats. Journal of Endocrinology 99 485-490.
54. Zhao AZ, Shinohara MM, Huang D, Shimizu M, Eldar-Finkelman H, Krebs EG, Beavo JA & Bornfeldt KE 2000 Leptin induces insulin-like signalling that antagonizes cAMP elevation by glucagon in hepatocytes. Journal of Biological Chemistry 275 11348-11354.
55. Zumoff B, Strain GW, Miller LK, Rosner W, Senie R & Seres D 1990 Plasma free and nonsex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. Journal of Clinical Endocrinology and Metabolism 71 929-931.